Lu Bai Selected Research

Carcinoma (Carcinomatosis)

9/2023	Different Expression Pattern of G Protein-Coupled Estrogen Receptor GPER1 in Esophageal Squamous Cell Carcinoma and Adenocarcinoma.
1/2022	LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lu Bai Research Topics

Disease

61	Neoplasms (Cancer) 05/2024 - 06/2009
11	Infections 01/2023 - 06/2012
10	Inflammation (Inflammations) 04/2024 - 03/2015
9	Lung Neoplasms (Lung Cancer) 11/2022 - 06/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2016
7	Carcinogenesis 09/2023 - 01/2017
6	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2020
6	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2015
5	Hypoxia (Hypoxemia) 04/2022 - 10/2020
4	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 09/2022
4	Fibrosis (Cirrhosis) 07/2020 - 07/2014
3	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2021
3	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 12/2021
3	Acute Lung Injury 10/2023 - 10/2020
3	Adenocarcinoma 09/2023 - 06/2017
3	Adenocarcinoma of Lung 01/2023 - 01/2022
3	COVID-19 09/2022 - 11/2021
3	Sepsis (Septicemia) 01/2022 - 10/2020
3	Diarrhea 01/2022 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2018
3	Virus Diseases (Viral Diseases) 01/2022 - 10/2013
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 09/2014
3	Wounds and Injuries (Trauma) 01/2021 - 12/2012
3	Glioma (Gliomas) 08/2020 - 01/2014
3	Ischemia 01/2020 - 09/2013
3	Radiation Pneumonitis 01/2019 - 06/2013
3	Pain (Aches) 01/2017 - 07/2012
2	Cardiotoxicity 04/2024 - 01/2018
2	Spinal Cord Injuries (Spinal Cord Injury) 04/2024 - 07/2012
2	Obesity 03/2024 - 11/2023
2	Bronchiolitis Obliterans Syndrome 03/2024 - 08/2022
2	Carcinoma (Carcinomatosis) 09/2023 - 01/2022
2	Nasopharyngeal Carcinoma 01/2023 - 09/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2022 - 07/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2022
2	Ischemic Stroke 01/2022 - 01/2020
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 12/2021
2	Tuberculosis (Tuberculoses) 01/2022 - 01/2022
2	Congenital Abnormalities (Deformity) 12/2021 - 05/2020
2	Necrosis 10/2021 - 11/2016
2	Cognitive Dysfunction 04/2021 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 07/2012
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2021
2	Myocardial Infarction 10/2020 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2013
9	RNA (Ribonucleic Acid)IBA 02/2024 - 12/2018
7	CytokinesIBA 01/2023 - 01/2016
7	Long Noncoding RNAIBA 03/2022 - 06/2017
6	Messenger RNA (mRNA)IBA 09/2023 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2018
4	EnzymesIBA 03/2024 - 11/2021
4	Analgesics (Analgesic Drugs)IBA 01/2023 - 07/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 09/2013
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2024 - 02/2024
3	Peptides (Polypeptides)IBA 03/2024 - 01/2020
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 07/2021
3	Contrast MediaIBA 01/2023 - 01/2018
3	VaccinesIBA 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2018
3	SolutionsIBA 03/2021 - 06/2009
3	Oxygen (Dioxygen)IBA 01/2020 - 07/2018
3	Interleukin-6 (Interleukin 6)IBA 11/2016 - 01/2014
2	Molecular Probes (Molecular Probe)IBA 04/2024 - 02/2024
2	TabletsIBA 04/2024 - 01/2024
2	GlucosidasesIBA 03/2024 - 02/2024
2	Monophenol Monooxygenase (Tyrosinase)IBA 03/2024 - 02/2024
2	AcetylcholinesteraseIBA 03/2024 - 02/2024
2	NF-kappa B (NF-kB)IBA 10/2023 - 12/2021
2	CholesterolIBA 09/2023 - 06/2020
2	Arginine (L-Arginine)FDA Link 01/2023 - 01/2017
2	LipidsIBA 01/2023 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 07/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
2	Small Interfering RNA (siRNA)IBA 11/2022 - 09/2015
2	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 03/2022
2	cyclic diadenosine phosphateIBA 10/2022 - 01/2022
2	6-methyladenineIBA 08/2022 - 01/2022
2	Chimeric Antigen ReceptorsIBA 01/2022 - 12/2021
2	NLR ProteinsIBA 01/2022 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	InflammasomesIBA 01/2022 - 12/2021
2	ChitinIBA 11/2021 - 12/2012
2	Arsenic Trioxide (Trisenox)FDA Link 05/2021 - 10/2019
2	AntioxidantsIBA 01/2021 - 06/2020
2	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2021

Therapy/Procedure

24	Therapeutics 04/2024 - 07/2010
13	Radiotherapy 01/2022 - 06/2013
8	Immunotherapy 04/2024 - 01/2021
5	Transplantation 03/2024 - 09/2016
5	Drug Therapy (Chemotherapy) 07/2021 - 01/2016
4	Hematopoietic Stem Cell Transplantation 12/2023 - 01/2020
3	Chemoradiotherapy 02/2024 - 01/2016
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2020
2	Photothermal Therapy 03/2022 - 01/2022
2	Cognitive Training 04/2021 - 01/2021